by Truveta Research | Jan 13, 2023 | Research, Research Insights
Intended for a scientific audience, Truveta Research Technical Reports are a new way of looking at the timely, representative, and de-identified data in Truveta Studio. The Truveta Research blog will surface insights shown in these Technical Reports for a broader...
by Truveta Research | Nov 2, 2022 | Research, Research Insights
UPDATE 1/11/2023: The analysis in this blog has been published as a part of a peer-reviewed paper in Frontiers in Public Health: Racial inequality in COVID treatment and in-hospital length of stay in the US over time. Many researchers have goals to conduct novel...
by Truveta Research | Oct 31, 2022 | Research, Research Insights
On February 17, 2022, Abbott voluntarily recalled powdered formula made in a Michigan facility due to complaints of Cronobacter sakazakii and Salmonella Newport contamination [1]. Datasembly reported that baby formula was out-of-stock at 31% of stores in April 2022...
by Truveta Research | Oct 4, 2022 | Research, Research Insights
Peripheral Artery Disease (PAD) is a common disease that causes the arteries in the extremities to narrow. Recently, as part of PAD Awareness Month, we investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or...
by Truveta Research | Sep 27, 2022 | Research, Research Insights
Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
by Truveta Research | Sep 22, 2022 | Research, Research Insights
Early in the pandemic, very little was known about the best treatment pathways for COVID-19, and there were no approved drug therapies available. Doctors were quoted saying, “To be honest, we didn’t know [how to treat patients]” [1]. The first approved COVID...
